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Contact inhibition of cell growth is essential for embryonic de-
velopment and maintenance of tissue architecture in adult organ-
isms, and the growth of tumors is characterized by a loss of
contact inhibition of proliferation. The recently identiﬁed Hippo
signaling pathway has been implicated in contact inhibition of
proliferation as well as organ size control. The modulation of the
phosphorylation and nuclear localization of Yes-associated protein
(YAP) by the highly conserved kinase cascade of the Hippo
signaling pathway has been intensively studied. However, cell-
surface receptors regulating the Hippo signaling pathway in
mammals are not well understood. In this study, we show that
Hippo signaling pathway components are required for E-cadherin–
dependent contact inhibition of proliferation. Knockdown of the
Hippo signaling components or overexpression of YAP inhibits the
decrease in cell proliferation caused by E-cadherin homophilic
binding at the cell surface, independent of other cell–cell interac-
tions. We also demonstrate that the E-cadherin/catenin complex
functions as an upstream regulator of the Hippo signaling path-
way in mammalian cells. Expression of E-cadherin in MDA-MB-231
cells restores the density-dependent regulation of YAP nuclear
exclusion. Knockdown of β-catenin in densely cultured MCF10A
cells, which mainly depletes E-cadherin–bound β-catenin, induces
a decrease in the phosphorylation of S127 residue of YAP and its
nuclear accumulation. Moreover, E-cadherin homophilic binding
independent of other cell interactions is sufﬁcient to control the
subcellular localization of YAP. Therefore, Our results indicate that,
in addition to its role in cell–cell adhesion, E-cadherin-mediated
cell–cell contact directly regulates the Hippo signaling pathway to
control cell proliferation.
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In unicellular organisms, cell growth and division are unlimitedand mainly controlled by nutrients in the environment. In
contrast, metazoans restrain cell growth and division through an
interplay between growth factor signaling and contact inhibition.
Regardless of external growth factor-containing medium and
active internal cellular metabolism, human cells restrict pro-
liferation and cell division when the culture becomes conﬂuent
(1). This so-called contact inhibition of proliferation is a well-
known property of normal differentiated tissues and needs to be
tightly regulated for proper tissue morphogenesis (2). Contact
inhibition is overcome in rapidly growing tissues during embry-
onic development, tissue regeneration, and wound healing.
Furthermore, uncontrolled growth because of the loss of contact
inhibition of proliferation is a hallmark of solid tumors (3, 4).
Despite these insights, the underlying regulatory mechanisms of
the contact inhibition of proliferation remain poorly understood,
although cadherin-mediated cell–cell adhesion is thought to play
an important role (2).
Cadherins are key regulators of embryonic development and
adult tissue homeostasis (5). Cadherins mediate Ca2+-dependent
cell adhesion and cell junction formation, and their cytoplasmic
domains are associated with various catenins that mediate cyto-
skeletal association and signaling (6). E-cadherin is expressed in
epithelial cells and intercellular homophilic binding of E-cadherin
leads to the formation of the epithelial junctional complex and
a tight polarized cell layer (7). Loss of E-cadherin expression
through genetic or epigenetic alterations promotes tumor pro-
gression and metastasis (8, 9). On the other hand, overexpression
of E-cadherin in cancer cells impedes tumor progression and in-
vasion (10–12), not only because of E-cadherin’s adhesive func-
tion at the cell surface, which physically blocks the movement of
cells and facilitates other cell–cell interactions, but also because of
its inhibition of β-catenin signaling and other growth signaling
pathways (12, 13). Independent of other cell–cell interactions,
homophilic binding of E-cadherin directly transduces growth in-
hibitory signals through modulation of growth factor receptor ty-
rosine kinase (RTK) and Src family kinase signaling pathways (13).
Recent studies suggest that Nf2 tumor-suppressor Merlin
plays a role in contact inhibition of proliferation by modulating
RTK signaling through interaction with cadherins and catenins
(14–16). Merlin directly associates with α-catenin to promote
maturation of the adherens junction (17) and links it to the
junctional polarity complex. Merlin is also known to regulate the
Hippo signaling pathway through its interaction with Kibra and
Expanded (18). The Hippo signaling pathway controls organ size
by inhibiting cell proliferation and promoting apoptosis. The
protein kinase cascade of the Hippo signaling pathway stimulates
the nuclear exclusion and inactivation of transcriptional coac-
tivator Yes-associated protein (YAP) and its paralog TAZ
(transcriptional activator with PDZ binding motif) (19). The core
kinase cascade of the pathway in mammals consists of the Ste20-
like protein kinase Mst1/2, the WW domain containing protein
WW45, the adaptor protein Mob, and nuclear Dbf2-related
(NDR) family protein kinase large tumor suppressor (Lats)1/2.
YAP has also been shown to be involved in contact inhibition,
as its phosphorylation and nuclear localization are regulated by
cell density through the Hippo signaling pathway in a Merlin-
dependent manner (20, 21).
The upstream mechanisms regulating Hippo pathway activa-
tion have not been studied as intensively as the kinase cascade
and regulation of YAP (22). In Drosophila, but not in mammals,
genetic studies have identiﬁed the Fat atypical cadherin as the
transmembrane protein acting upstream of the core Hippo ki-
nase cascade (23–25). Recently, in Drosophila, polarity proteins
including the apical transmembrane protein Crumbs and the
membrane-associated signaling proteins Lgl and aPKC have
been found to regulate the Hippo signaling pathway through
Expanded and Hippo (Hpo) (26, 27). However, transmembrane
receptors that deliver the contact-dependent growth inhibitory
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signals to the Hippo signaling pathway in mammals have not yet
been identiﬁed. In this study, we show that E-cadherin directly
mediates contact inhibition of proliferation via Hippo signaling
pathway components and the regulation of the subcellular lo-
calization of YAP.
Results
Hippo Pathway Components Are Required for E-Cadherin–Dependent
Contact Inhibition of Proliferation. E-cadherin homophilic ligation
directly regulates cell proliferation independent of other cell–cell
interactions (13). This mechanism is dependent on cadherin-
associated β-catenin, as depletion of β-catenin eliminates pro-
liferation inhibition by E-cadherin ligation (13) (Fig. 1). Similar
to depletion of β-catenin, knockdown of α-catenin in MCF-7 and
SW480/E-cadherin cells blocked the inhibition of cell prolif-
eration by E-cadherin (Fig. 1 A and B). E-cadherin ligation also
partially inhibits EGFR-mediated growth signaling by inhibiting
the transphosphorylation of Tyr-845 of EGFR by Src family
kinases (13).
Recent studies suggest that the Nf2 tumor-suppressor Merlin
plays an important role in the contact inhibition of proliferation
(14, 15, 28). Upon cell-cell contact, together with the adaptor
protein NHERF (Na+/H+ exchanger regulatory factor), Merlin
interacts with the cadherin/catenin complex and attenuates
downstream signaling from the EGFR (15). We thus wished to
determine whether the proliferation inhibitory role of E-cadherin,
regardless of other cell–cell interactions, depends on Merlin or
NHERF. To address this question, we performed proliferation
assays using E-cadherin–coated beads to create pure cadherin
contacts (13). Binding of extracellular domain of E-cadherin-IgG
Fc domain chimera (Fc-hE)-coated protein-A microspheres
caused a decrease in proliferation of control MCF-7 cells (control
siRNA), as shown previously (13), whereas depletion of Merlin
or NHERF using speciﬁc siRNA reversed the proliferation in-
hibitory signal fromE-cadherin bead homophilic ligation (Fig. 1C
and D). This ﬁnding suggests that Merlin and NHERF are re-
quired for proliferation inhibition mediated by E-cadherin liga-
tion at the cell surface.
Importantly, Merlin is known to be an upstream regulator of
the Hippo signaling pathway, which has been implicated in organ
size control, as well as contact inhibition of growth (18, 20, 21).
We therefore examined whether E-cadherin mediates contact
inhibition through the Hippo signaling pathway in MCF-7 and
MCF10A cells. siRNA-mediated depletion of the Lats1/2 kina-
ses, which phosphorylate and regulate the activity of YAP,
inhibited the E-cadherin bead-induced decrease in cell pro-
liferation, similar to depletion of β-catenin (Fig. 1 E and F, and
Fig. S1A). Depletion of endogenous Kibra, which is known to
bind Merlin and activate the Hippo signaling pathway, reversed
the E-cadherin bead-induced proliferation inhibition (Fig. 1G).
These data show that upstream and downstream components of
the Hippo signaling pathway are required for E-cadherin ligation-
mediated contact inhibition of proliferation. Knockdown of the
Mst1/2 kinase, however, showed no signiﬁcant effect on the cell
proliferation inhibition induced by E-cadherin ligation at the
surface of MCF10A cells (Fig. 1H and Fig. S1B), suggesting that
it may not be involved, similar to other recent ﬁndings for mouse
embryonic ﬁbroblasts (MEFs) using knockout mice (29, 30). As
proposed, another kinase may mediate phosphorylation of Lats
kinases in these cells.
E-Cadherin Is Required for Cell Density-Dependent YAP Subcellular
Localization. The phosphorylation and localization of YAP is
regulated by cell density via the Hippo signaling pathway (21). In
sparse cell cultures, YAP is predominantly localized in the nu-
cleus, but in dense cell cultures it is phosphorylated by Lats kinase
and translocated to the cytoplasm. Because depletion of Hippo
signaling components (Merlin, Lats1/2, and Kibra) resulted in the
loss of proliferation inhibition by E-cadherin ligation, we hy-
pothesized that E-cadherin is an upstream regulator of the Hippo
signaling pathway. We therefore investigated whether YAP lo-
calization is controlled by the E-cadherin using MDA-MB-231
cell lines, which express different types of doxycycline-inducible
Fig. 1. Hippo pathway components are required for E-cadherin–dependent contact inhibition of proliferation. At 12 to 24 h posttransfection of siRNA, cells
were harvested and seeded at very low density on ﬁbronectin-coated coverslips. Fc-hE–coated microspheres were presented to create pure E-cadherin
homophilic binding. Anti-HLA or polylysine-coated microspheres were used as controls for bead binding to MCF-7 or MCF10A cells, respectively. Control and
Fc-hE beads were bound for 24 h and cells were treated with 50 μM of BrdU for the last 6 h. BrdU incorporation was calculated by counting the number of
positive BrdU immunoﬂuorescence staining cells from the population of completely isolated, DAPI stained cells. (A and B) Depletion of α-catenin blocks
E-cadherin–dependent contact inhibition of proliferation in SW480/E-cadherin (A) or MCF-7 (B) cells. (C and D) Depletion of Merlin (C) or NHERF (D) eliminates
E-cadherin–dependent contact inhibition of proliferation in MCF-7 cells. (E and F) Depletion of β-catenin or Lats1/2 inhibits the E-cadherin bead-induced
inhibition of proliferation in MCF-7 (E) and MCF10A (F) cells. Decrease of endogenous β-catenin or Lats1 protein levels by siRNA transfection in MCF-7 cells is
shown in Fig. S1A. (G) Depletion of Kibra leads to the elimination of the E-cadherin bead-induced inhibition of proliferation in MCF10A cells. (H) Compared
with β-catenin or Lats1/2 depletion, knockdown of Mst1/2 does not inhibit E-cadherin–dependent contact inhibition of proliferation in MCF10A cells. Decrease
of endogenous Mst1/2 by siRNA transfection in MCF-7 cells is shown in Fig. S1B.
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E-cadherin (11). The parental MDA-MB-231 cell line expresses
no E-cadherin (11). In sparse cell cultures, most YAP protein was
localized in the nucleus of all MDA-MB-231 cell lines, whether
expressing E-cadherin or the E-cadherin–negative parental
MDA-MB-231 cells (Fig. 2 A and C). The YAP protein remained
localized in the nucleus of parental MDA-MB-231 cells, even
under high cell density (Fig. 2 B and C). Interestingly, doxycy-
cline-induced expression of full-length E-cadherin caused the
redistribution of YAP from nucleus to cytoplasm in dense cell
cultures (Fig. 2 B and C), suggesting that E-cadherin is required
for the density-dependent regulation of YAP localization. In-
duced expression of E-cadherin Δp120 mutant (which is in-
capable of binding to p120) in MDA-MB-231 cells showed
density-dependent YAP subcellular localization, indicating that
direct binding of p120 to E-cadherin is not necessary for the
E-cadherin–dependent YAP localization control. However, ex-
pression of an E-cadherinΔβ-catenin mutant, which binds neither
endogenous β-catenin nor α-catenin but can still mediate some
degree of physical cell adhesion (11), showed no density-dependent
YAP subcellular localization regulation (Fig. 2 B and C). A ma-
jority of these cells exhibited YAP in the nucleus, even at high
cell density. Expression of an E-cadherin/α-catenin fusion, which
bypasses the need for β-catenin to mediate strong cell adhesion
(11), also mediated density-dependent redistribution of YAP to
the cytoplasm. Taken together, these results show that E-cadherin
regulates YAP localization in response to cell density and that E-
cadherin associated β-catenin and α-catenin, but not p120, are
involved in regulating the Hippo signaling pathway.
Depletion of β-Catenin Induces the Nuclear Accumulation of YAP in
Dense Cell Cultures. Induced expression of E-cadherin in MDA-
MB-231 cells demonstrates its involvement in the regulation
of YAP sublocalization in response to cell density. In addition,
E-cadherin–blocking antibody was found to increase nuclear
YAP in internal cells of mouse preimplantation embryos (31).
However, either cadherin expressionor treatmentwithE-cadherin–
blocking antibody could potentially inﬂuence other cell inter-
actions indirectly through its role in cell–cell adhesion. Nonethe-
less, our ﬁndings suggest that E-cadherin–associated β-catenin
and α-catenin speciﬁcally are involved in regulating the Hippo
signaling pathway. To test whether cadherin-associated catenins
regulate contact-dependent Hippo signaling independent of the
cell-adhesion function of E-cadherin, we depleted endogenous
β-catenin in MCF10A cells through siRNA transfection and ex-
amined the localization of YAP at different cell densities. We ﬁrst
conﬁrmed previous observations that YAP is excluded from the
nuclei of MCF10A cells when they reach high density and that
siRNA-mediated depletion of Lats1/2 leads to nuclear accumu-
lation of YAP in dense cell cultures (Fig. 3 A and B). Similar to
results in previous studies (13), depletion of β-catenin did not lead
to the loss of adhesion, presumably because of functional com-
pensation byplakoglobin (γ-catenin), a related cadherin-associated
junctional protein (32, 33). β-Catenin depletion also did not
change the expression level and localization pattern of E-cadherin
expression (13). Depletion of β-catenin in densely cultured
MCF10A cells resulted in increased nuclear accumulation of YAP
(Fig. 3 A and B) and decreased YAP phosphorylation on the S127
residue (Fig. 3C). Similar results were observed for A431 cells and
MCF-7 cells, supporting the generality of the phenomena (Fig.
S2). In sparse cell cultures, depletion of β-catenin or Lats1/2 did
not signiﬁcantly change the nuclear localization of YAP protein
(Fig. 3B). Because almost all of the β-catenin proteins in dense
epithelial cells lacking Wnt signaling are E-cadherin–bound (13),
these data suggest that E-cadherin–bound β-catenin can inﬂuence
the downstream activity of the Hippo signaling pathway.
E-Cadherin Directly Controls the Localization of YAP, and YAP Is
Involved in Growth Inhibition by E-Cadherin. To further test whether
E-cadherin homophilic binding independent of other cell inter-
actions directly controls the Hippo signaling pathway, we exam-
ined whether homophilic E-cadherin ligation alone could change
the subcellular localization of YAP. In sparse cell cultures,
most YAP proteins were localized in the nucleus of MCF10A
cells (Fig. 3B). Interestingly, either platingMCF10A cells sparsely
on E-cadherin protein-coated coverglass (Fig. 4A) or attachment
of E-cadherin beads to the surface of isolated MCF10A cells
(Fig. 4B and Fig. S3) led to a decrease in nuclear YAP relative to
cytoplasmic YAP. Moreover, siRNA-mediated depletion of ei-
ther β-catenin or Lats1/2 inhibited the effect of E-cadherin liga-
tion, resulting in increased nuclear YAP (Fig. 4 A and B, and Fig.
S3), suggesting that regulation of YAP activity by E-cadherin
depends on E-cadherin–bound β-catenin and the Hippo signaling
kinase cascade.
The involvement of E-cadherin in the regulation of the Hippo
signaling pathway led us to test the effect of increased YAP
activity on E-cadherin–dependent contact inhibition of prolif-
eration. The Hippo signaling pathway regulates YAP through
either of two mechanisms: phosphorylation of S127 residue
Fig. 2. E-cadherin expression regulates cell density-dependent redis-
tribution of YAP from nucleus to cytoplasm. (A and B) Parental MDA-MB-231
cells and stable MDA-MB-231 clones, which contain doxycycline-inducible
full-length E-cadherin, E-cadherin Δβ-catenin, E-cadherin–α-catenin fusion,
or E-cadherin Δp120 transgene were seeded on ﬁbronectin-coated coverslips
in 24-well plates sparsely (1 × 104 cells) or densely (2 × 105 cells). Wild- or
mutant-type E-cadherin expression was induced by the treatment of 2 μg/mL
of doxycycline for 2 d. Cells were cultured under sparse (A) or dense (B)
conditions, and endogenous YAP was stained by anti-YAP antibody. (Mag-
niﬁcation, 200×.) (C) Subcellular localization of YAP in A and B was quan-
tiﬁed using Blobﬁnder.
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and nuclear exclusion (20), or control of YAP levels through
phosphorylation by CK1, and subsequent SCFβ-TRCP-mediated
ubiquitination, and degradation (34). We therefore generated
MCF10A cell lines stably overexpressing Flag-tagged YAP or
phosphorylation deﬁcient mutant Flag-tagged YAP S127A (Fig.
5A) and performed proliferation assays using E-cadherin bead to
stimulate contact inhibition. In contrast to control MCF10A
cells, overexpression of YAP or YAP S127A in MCF10A cells
blocked the proliferation inhibition induced by E-cadherin bead
ligation (Fig. 5B). Taken together, these ﬁndings suggest that
E-cadherin homophilic ligation mediates contact inhibition of
proliferation through regulation of YAP activity.
Discussion
In this study, we demonstrate that Hippo signaling-pathway
components are required for E-cadherin–mediated contact in-
hibition of proliferation. Depletion of Hippo signaling-pathway
components (Merlin, Lats, and Kibra) or overexpression of YAP
blocks the E-cadherin–mediated contact inhibition of prolifer-
ation. Because our experiments examine the role of E-cadherin
homophilic ligation in contact inhibition, independent of other
cell interactions, these ﬁndings also suggest that E-cadherin di-
rectly stimulates the Hippo tumor-suppressor pathway to trigger
growth-inhibitory signaling. Indeed, we ﬁnd that the E-cadherin–
catenin complex regulates the nuclear localization of YAP, the
transcriptional effector of the Hippo pathway. Re-expression
of E-cadherin in MDA-MB-231 cells reconstitutes the density-
dependent control of YAP subcellular localization; knockdown
of β-catenin in densely cultured MCF10A cells induces the nu-
clear accumulation and a decrease in the phosphorylation of
S127 residue of YAP; and homophilic ligation of E-cadherin
alone directly decreased the level of nuclear YAP relative to the
cytoplasmic YAP in a process dependent on β-catenin and Lats1/2.
These results provide the evidence that E-cadherin homophilic
binding, independent of other cell–cell interactions, directly
regulates the Hippo signaling pathway. Therefore, we identify
E-cadherin as an upstream cell-surface receptor that regulates
Hippo signaling in mammalian cells (Fig. 6).
Although the signal transduction cascade of the core kinases in
the Hippo signaling pathway has been intensively studied, the
upstream cell-surface regulators have not been well understood
(22). InDrosophila, the Fat atypical cadherin has been identiﬁed as
a transmembrane protein regulating the Hippo signaling pathway
within epithelial cells (23). However, in mouse, the homolog,
Fat4 is predominantly expressed in mesenchymal cells and Fat4
mutant mice exhibited none of the phenotypes associated with
defects in the Hippo signaling pathway nor any effects on Yap or
Lats1 (24, 25). These results suggest that Fat4 may not be an im-
portant cell-surface receptor for the Hippo signaling pathway in
mammals; andwe propose instead that classic cadherins, especially
E-cadherin, play this role.
We also identify NHERF as a potentially unique upstream
membrane-associated regulator of Hippo signaling, because de-
pletion of NHERF blocks the E-cadherin ligation-dependent
inhibition of proliferation. NHERF is an adaptor protein that is
known to bind numerous proteins, including Merlin, β-catenin,
EGFR, TAZ, and YAP (35). In fact, YAP had been previously
Fig. 3. Depletion of β-catenin in MCF10A cells induces the nuclear accu-
mulation of YAP and decreases the phosphorylation of the YAP S127 residue
in dense cell cultures. (A and B) MCF10A cells transfected with control,
β-catenin, or Lats1/2 siRNA (positive control) were harvested and 2 × 105 cells
were seeded on ﬁbronectin-coated coverslips in 24-well plates for 2 d more.
(Magniﬁcation, 400×.) Localization of endogenous YAP was identiﬁed by
immunoﬂuorescence staining (A) and quantiﬁed (B). (C) Knockdown of
β-catenin or Lats1/2 decreases the phosphorylation of YAP S127 residue in
densely cultured MCF10A cells.
Fig. 4. Homophilic ligation of E-cadherin controls the localization of en-
dogenous YAP protein. MCF10A cells transfected with control, β-catenin, or
Lats1/2 siRNA were plated at very low density. (A) Cells were plated on either
E-cadherin protein and ﬁbronectin-coated coverslips (FN + Fc-hE), or ﬁbro-
nectin and Fc domain alone as control (FN + hFc). (B) Fc-hE coated or poly-
lysine coated control microspheres were applied to the surface of MCF10A
cells. After 24 h, endogenous YAP was stained and the nuclear-to-cytoplasmic
YAP ratio (NCR) was quantiﬁed.
Fig. 5. YAP overexpression blocks the proliferation inhibitory effect of
E-cadherin. (A) MCF10A cells stably expressing Flag-YAP or Flag-YAP S127A
were generated. Endogenous E-cadherin protein level and overexpression
of exogenous protein was veriﬁed by Western blot. (B) Overexpression of
YAP or YAP S127A inhibits the E-cadherin–dependent contact inhibition of
proliferation.
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identiﬁed as a c-Yes–associated protein interacting with c-Yes
and NHERF at the apical plasma membrane (36). Further work
will be needed to determine whether NHERF mediates contact
inhibition directly through the Hippo pathway and whether it is
an important component of the Hippo signaling pathway in other
tissues and developmental contexts.
Although we found that several Hippo pathway components,
including the YAP protein kinase Lats1/2, are required for
E-cadherin–mediated contact inhibition, the mammalian Hpo
kinase orthologs Mst1/2 did not appear to be required. Mst1 and
Mst2 serine/threonine kinases, are known to associate with adaptor
protein WW45 to phosphorylate and activate Lats kinase (18). We
cannot rule out the possibility that Mst1/2 remaining after siRNA
transfection (<∼10%) (Fig. S1B) are sufﬁcient to mediate Hippo
signaling. However, there is precedence for Mst1/2 independent
Hippo pathway signaling. Mst1/2 are not required for cell density-
stimulated YAP cytoplasmic translocation in MEFs lacking
both genes (29). The inducible removal of Mst1/2 in newborn
mice shows tissue-speciﬁc organ size control (30). It has been
suggested that kinases distinct from Mst1/2 control Lats phos-
phorylation and Hippo signaling in MEF cells (29, 37). Further-
more, it has been found that FAT functions to regulate the levels
of Warts/Lats independent of Hippo/Mst in Drosophila (38).
However, we see no changes in Lats1/2 levels as result of β-catenin
knockdown (Fig. S1A).
The detailed molecular mechanism by which E-cadherin
homophilic ligation stimulates the Hippo pathway is not yet clear.
Importantly, we ﬁnd that cadherin-associated α- and β- catenins
are involved in Hippo signaling. Both catenins are required for E-
cadherin–mediated contact inhibition. Unlike β-catenin, knock-
down of α-catenin in MCF-7 cells disrupts cell–cell adhesion (Fig.
S1 C and D), making it hard to distinguish from indirect effects
because of the loss of other cell–cell interactions. Nonetheless,
expression of an E-cadherin–α-catenin fusion in MDA-MB-231
cells stimulates the redistribution of YAP from nucleus to cyto-
plasm in a density-dependent manner, suggesting that E-cadherin–
bound α-catenin contributes to the regulation of the Hippo sig-
naling pathway. A recent study revealed that α-catenin acts as
a negative regulator of Yap through binding to 14-3-3–bound
YAP (39). In contrast to our ﬁndings, the regulation of YAP
phosphorylation and activity was shown to be independent of the
Hippo pathway core kinases Lats1/2, cadherin proteins, and
β-catenin. This study either reveals a completely distinct role for
α-catenin in YAP regulation from the cadherin-catenin–mediated
contact inhibition we are reporting, or somehow it missed an
important role for these components.
Importantly, knockdown of β-catenin resulted in increased
nuclear accumulation of YAP and decreased YAP phosphory-
lation on S127 in dense cell cultures. As shown in our previous
study (13), proliferation inhibition mediated by E-cadherin li-
gation depends on E-cadherin–bound β-catenin, but not on the
transcriptional activity of nuclear β-catenin. Depletion of β-catenin
in dense cell cultures in the absence of Wnt signaling mainly
decreases E-cadherin–β-catenin interaction because the cyto-
plasmic and nuclear levels of β-catenin are kept low by degra-
dation (40). In contrast to α-catenin, depletion of β-catenin in
mammalian cells does not disrupt cell–cell adhesion (ref. 13 and
present study), presumably because of functional compensation
by plakoglobin (32, 33). Therefore, β-catenin knockdown in this
context selectively reveals its role in Hippo signaling indepen-
dent of its role in cell adhesion or Wnt signaling. Note also that
that this context, β-catenin bound to E-cadherin may serve a tu-
mor suppressor-like function by controlling the Hippo signaling
pathway, in contrast to its more well-known function as an on-
cogene in the context of the Wnt signaling pathway. This ﬁnding
is not really surprising as E-cadherin, which functions in associ-
ation with catenins, is well known to be a tumor suppressor.
Recent studies have also shown that the Hippo signaling pathway
restricts Wnt signaling either by TAZ interaction with DVL2
(41) or by inhibiting the interaction of YAP with β-catenin on
target genes in the nucleus (42). These interactions of TAZ/YAP
with the Wnt pathway are distinct from our observations of a
Wnt pathway-independent role for β-catenin upstream of the
Hippo signaling pathway.
Molecular components and interactions are known that can
potentially explain the link between cadherins and the Hippo
signaling pathway. Merlin interacts with Hippo pathway com-
ponents Expanded and Kibra, which interacts with the Hpo ki-
nase in Drosophila (18). Merlin also interacts with the cadherin-
associated catenins, which we have implicated in the pathway
(14–17, 28). NHERF is another potential candidate that may
provide part of a molecular link, and there may be other com-
ponents as well. Ultimately, it will be important to understand
how E-cadherin receptor activation (i.e., homophilic binding
by another E-cadherin protein) alters these protein interactions
or their posttranslational modiﬁcations so as to activate down-
stream signaling events in the Hippo pathway.
E-cadherin can effect the growth of cells in tissues in a number
of ways. Its adhesive function at the cell surface leads to a junc-
tional barrier, limiting the accessibility of growth factors to their
receptors, inhibition cell movement out of the epithelium, and
the establishment of many cell–cell interactions that indirectly
inhibit cell growth, including tight junction, gap junctions, and
juxtacrine ligand-receptor interaction (43). Furthermore, E-
cadherin also directly interacts with other effector proteins, in-
cluding β-catenin, to inhibit its nuclear transport during Wnt
signaling, and receptor tyrosine kinases to regulate their signaling
activities (9). E-cadherin is also known to modulate the activity of
Rho/Rac family GTPases (9) and is involved in the establishment
and maintenance of polarity (44). Linking E-cadherin to the Hippo
signaling pathway adds an important new aspect of cadherin
function andmay help explain how its adhesive functions and other
signaling interactions are integrated to regulate cell growth in
various developmental processes or adult tissue homeostasis.
Methods
Preparation of Protein-Coated Microspheres and Protein-Coated Glass
Coverslips. Protein A-coated beads were prepared as described in ref. 13,
with minor modiﬁcations. Twenty-ﬁve microliters of protein A-coated
polystyrene microspheres (Bangs Laboratories) were washed in 1 mM so-
Fig. 6. A model for an E-cadherin–mediated Hippo signaling pathway.
Homophilic binding of E-cadherin between two cells stimulates the Hippo
signaling pathway, which control proliferation by inhibiting the activity of
YAP in the nucleus. Broken arrows indicate steps unresolved by the present
study (see Discussion for more details).
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dium acetate, pH 3.9, followed by washing two times with beads buffer
(20 mM Hepes, 50 mM NaCl, and 2 mM CaCl2, pH 8.0). Then, 5 μg Fc-hE
recombinant protein was bound to the microspheres, suspended in 50 μL of
beads buffer, and incubated for 2 h at 4 °C with shaking. Anti-HLA antibody
(for MCF-7 cells) or polylysine (for MCF10A cells) was used as control. The
coated beads were washed two times with beads buffer and incubated with
1% BSA and 5 μg human Fc protein in 50 μL of beads buffer for 1 h to block
nonspeciﬁc protein binding. After being washed three times in beads buffer,
beads were resuspended in 250 μL of 2 mM CaCl2 and 1 mM MgCl2 con-
taining HBSS++. After brief sonication in the cup-horn sonicator to dissociate
bead aggregates, 15 μL of beads were transferred to coat the surface of the
cells. The experiments were also done using protein-coated glass coverslips,
in which coverslips were coated overnight at 4 °C with 10 μg of ﬁbronectin
along with either 10 μg of Fc-hE or 10 μg of anti-HLA antibody. Coverslips
were washed in PBS and coated with 1% BSA in PBS for 1 h before
plating cells.
E-Cadherin Bead-Based Proliferation Assay. Cell monolayers were washed
twice in HBSS++ and incubated with 0.02% trypsin in HBSS++ for 30 min. The
cells were spun down and resuspended in complete medium. Next, 1,500 cells
per well were transferred to 24-well plates containing 10 μg of ﬁbronectin-
coated coverslips and incubated for 4 h to allow cell attachment. After
adding 15 μL of antibody or protein-coated beads, cells were incubated for
24 at 37 °C and 5% CO2. Six hours before ﬁxing cells, 50 μM BrdU was added.
Coverslips were washed and BrdU incorporation was detected by immuno-
ﬂuorescence staining using an anti-BrdU monoclonal antibody, whereas
nuclei were detected by staining with DAPI. The BrdU-labeled cells were
counted from the population of completely isolated cells present on the
coverslips, and the percentage of BrdU incorporation in this population was
calculated. To examine the effect of E-cadherin bead on localization of
YAP, MCF10A cells were cultured in DMEM/F12 medium supplemented with
5% of horse serum, 0.5 μg/mL hydrocortisone, 100 ng/mL cholera toxin,
and 10 μg/mL insulin. E-cadherin beads were attached as described above
and endogenous YAP protein was determined by indirect immunoﬂuores-
cence staining.
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